RESMETIROM vs REVUMENIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RESMETIROM vs REVUMENIB: Safety Overview
| Metric | RESMETIROM | REVUMENIB |
|---|---|---|
| Total FAERS Reports | 881 | 371 |
| Deaths Reported | 26 | 49 |
| Death Rate | 3.0% | 13.2% |
| Hospitalizations | 50 | 93 |
| Average Patient Age | 58.1 yrs | 46.4 yrs |
| % Female Patients | 65.3% | 47.6% |
| FDA Approval Date | Mar 14, 2024 | Nov 15, 2024 |
| Manufacturer | Madrigal Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |